Predictive value of preoperative albumin-bilirubin score and other risk factors for short-term outcomes after open pancreatoduodenectomy

Table 1 Patient characteristics, n (%)

Patient characteristic	n = 347
Male gender	193 (55.6)
Age (yr), median (IQR)	69 (61-76)
BMI, median (IQR)	25.2 (22.5-28.4)
Bilirubin (µmol/L), median (IQR)	21 (10-84)
Albumin (g/L), median (IQR)	41 (38-44)
ALBI score, median (IQR)	-2.6 (-3.0 to -2.0)
ALBI grade
1	173 (50.3)
2	146 (42.4)
3	25 (7.3)
ASA score
1	10 (2.9)
2	136 (39.2)
3	197 (56.8)
4	4 (1.2)
Operation type
PPPD	175 (50.4)
Whipple	172 (49.6)
Pathology
Pancreatic carcinoma	170 (49.0)
Bile duct carcinoma	36 (10.4)
Duodenal carcinoma	9 (2.6)
Ampullary carcinoma	46 (13.6)
NET	27 (7.8)
IPMN	16 (4.6)
Other	43 (12.4)
Soft pancreatic texture, n (%) (n = 307)	164 (53.4)
Duct diameter (mm), median (IQR)	3 (3-5)
Anastomosis type
PJA duct to mucosa	241 (69.5)
PJA invagination	94 (27.1)
PGA	12 (3.5)
Blood loss (ml), median (IQR)	400 (300-563)
Somatostatin use	185 (53.3)
Length of hospitalization (d), median (IQR)	14 (10-23)
Clavien-Dindo
0	164 (47.3)
I	9 (2.6)
II	79 (22.8)
IIIa	18 (5.2)
IIIb	32 (9.2)
IV	27 (7.8)
V	18 (5.2)
Main reason of postoperative complications
No complications	164 (47.3)
Pancreatic fistula	66 (19.0)
Haemorrhage	20 (5.8)
Biliary fistula	13 (3.7)
Abscess	38 (11.0)
Other	52 (15.0)
Pancreatic fistula
0 and BL	264 (76.1)
B and C	83 (23.9)
Reoperation	74 (21.3)
Death	18 (5.2)

IQR: Interquartile range; BMI: Body mass index; ALBI: Albumin-bilirubin; ASA score: American Society of Anesthesiologists score; PPPD: Pylorus-preserving pancreatoduodenectomy; NET: Neuroendocrine tumour; IPMN: Intraductal papillary mucinous neoplasm; PJA: Pancreatico-jejunal anastomosis; PGA: Pancreatico-gastric anastomosis; BL: Biochemical leak.